HPV vaccine Gardasil has already been adopted as a future standard treatment in Texas, with several states potentially follwing suit.
The recent approval of Januvia gives a strong boost for the company.
A promising array of new products makes up for drops in sales of old products due to patent expirations. As of the end of 2006, Merck has 21 products in Phase II clinical trials.